Skip to main content
Earnings Labs
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX)

NASDAQ·Healthcare·Biotechnology

$8.51

+5.06%

Mkt Cap $431.48M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (4 analysts)

$14.50

Range $14.00$15.00

Implied Upside

+70.4%

Consensus $14.50 vs current $8.51